Revolving doors: board memberships, hedge funds, and the FDA chiefs responsible for regulating industry
At his public confirmation hearing in late 2021, Robert Califf, President Biden’s nominee to lead the US Food and Drug Administration (FDA), faced pointed questions about his financial relationships with industry.Bernie Sanders, the senator from Vermont, …